Date: September 30, 2026

Board Meeting Outcomes

  • The company has received In-Principle Approval for preferential issue of 15,30,000 (Fifteen Lakh Thirty Thousand) equity shares under Regulation 28(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Approval received from both National Stock Exchange of India Ltd. and BSE Limited on September 29, 2026
  • This disclosure is in compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July, 2023

Impact of Approval

  • Receipt of the In-Principle Approvals enables the Company to proceed with the preferential issue and allotment of equity shares
  • Subject to fulfilment of the conditions specified in the approval letters and compliance with applicable statutory and regulatory requirements
  • The proceeds from the preferential issue shall be utilized for the purposes as approved by the shareholders and disclosed in the explanatory statement to the notice convening the general meeting

Validity Period

  • The approvals shall remain valid for the preferential issue and allotment of equity shares, subject to the terms, conditions and validity period specified in the respective approval letters issued by NSE and BSE

Compliance Officer

  • Ajay Shrivastava, Company Secretary and Compliance Officer, signed the disclosure document